Litewave AI

Vendor

External enrichment

CompanyLitewave AIAutomated

Compliance

Government
  • FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27

Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.

1 agent

Browse all 1 agent in the registry →

Litewave AI - GMP Intelligence Platform for Pharma Manufacturing

Litewave AI

Not rated

AWS Marketplace

Litewave AI is an AI-native GMP Intelligence Platform for pharmaceutical and API manufacturing, delivered as SaaS from AWS via AWS Marketplace. Start with Batch Review; Compliance (Digitize + Comply): Litewave overlays your existing records and systems - paper batch records, MES, LIMS, and ERP, to unify GMP evidence into a traceable, AI-ready fabric. Generate AI-assisted Batch Verification Reports with configurable GMP checks, enable review-by-exception, and surface data integrity gaps to accelerate batch disposition and improve inspection readiness. As you expand, Litewave can connect compliance to performance by correlating supplier variability to yield, surfacing golden-batch drivers, and highlighting process/equipment risk signals. Designed to support 21 CFR Part 11 and EU Annex 11 expectations with governance controls such as role-based access and audit trails. Private/on-prem deployments, custom integrations (QMS/ERP/LIMS), and additional modules are available via Private Offer.

Cybersecurity & ITSaaS
Provenance reach4 of 12
UnknownSource Confirmed
PricingPaid3 plans listed
Evidence riskHigh